SCHEMBL7097618

SCHEMBL7097618

CC(C(O)c1ccc(Cl)cc1)N1CCN(Cc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
KDM4E B2RXH2 4/20 0.54
MAPT P10636 3/20 0.54
GAA P10253 4/20 0.51
TSHR P16473 2/20 0.51
LMNA P02545 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
POLB P06746 1/20 0.51
THRB P10828 1/20 0.51
HPGD P15428 1/20 0.51
KCNH2 Q12809 3/20 0.48
HSD17B10 Q99714 1/20 0.47
ADORA3 P0DMS8 2/20 0.47
CNR1 P21554 2/20 0.47
HRH1 P35367 2/20 0.47
OPRK1 P41145 2/20 0.47
GHSR Q92847 2/20 0.47
NR1I2 O75469 1/20 0.47
PDE4D Q08499 1/20 0.47
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311270 0.83 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL4469097 0.78 SIGMAR1 (0.58) ALDH1A1KDM4EMAPTGAALMNA
SCHEMBL9417094 0.76 ALDH1A1 (0.90) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL4473753 0.73 KDM4E (0.59) KDM4ETSHRLMNAKCNH2HRH1
SCHEMBL3519518 0.72 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL5571042 0.70 ALDH1A1 (0.97) ALDH1A1KDM4EMAPTGAATSHR
Hydrochloric Acid SCHEMBL8843605 0.69 ALDH1A1 (0.93) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL5573167 0.69 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL9689242 0.69 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL9416927 0.68 ALDH1A1 (0.73) ALDH1A1KDM4EMAPTGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0901469-B1 ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS UNIV MONASH (AU) 2003-08-27 EP disclosed
US-6232314-B1 SUCH AS 1-(2-(4-CHLOROPHENYL)-2-HYDROXY)ETHYL-4-(3,5-BIS(1,1-DIMETHYLETHYL)-4 -HYDROXYPHENYL)METHYLPIPERAZINE; USED TO TREAT STROKE, CARDIAC ARREST, ISCHAEMIA, HYPOXIA, HYPOGLYCAEMIA, EPILEPSY, AND AMYOTROPHIC LATERAL SCLEROSIS MONASH UNIVERSITY (AU) 2001-05-15 US disclosed
EP-0901469-A4 ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS UNIV MONASH (AU) 2000-11-15 EP disclosed
EP-0901469-A1 ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS MONASH UNIVERSITY (AU) 1999-03-17 EP disclosed
WO-1997043259-A1 ARYLALKYLPIPERAZINE COMPOUNDS AS ANTIOXIDANTS MONASH UNIVERSITY (AU) 1997-11-20 WO disclosed